Use of bisphosphonates and reduced risk of colorectal cancer.
// CONCLUSION The use of oral bisphosphonates for more than 1 year was associated with a 59% relative reduction in the risk of colorectal cancer, similar to the recently reported association of this drug class with reduction in breast cancer risk.
(via J. Clin Oncol April 2011)
